Literature DB >> 15868427

Effect of axillary lymphadenectomy on breast carcinoma survival.

Sue A Joslyn1, Badrinath R Konety.   

Abstract

PURPOSE: To determine the effect of axillary lymphadenectomy on breast carcinoma survival, and to determine racial and age differences in the extent of axillary lymphadenectomy.
METHODS: Cases were 257,157 women diagnosed with breast carcinoma in the Surveillance, Epidemiology and End Results program from 1988 through 2000. Variables included number of lymph nodes removed, number of positive lymph nodes, ratio of positive nodes to number of nodes removed, use of radiation therapy, surgery (breast conserving surgery versus mastectomy), stage, age, race, and hormone receptor status. Correlation statistics were used to determine associations between survival and lymph node variables for all cases and when stratified by stage. Kaplan-Meier survival analyses were used to compare survival by lymph node categories overall and stratified by stage. Cox regression analyses were used to determine factors associated with survival.
RESULTS: Older women were significantly less likely to have lymph nodes examined and lymph node involvement compared to younger women, and black women were significantly less likely to have lymph nodes examined, but were significantly more likely to have lymph node involvement compared to white women. Risk of death was significantly reduced for cases who had lymphadenectomy compared to those who did not. For cases diagnosed at stage IIA or higher, risk of death increased significantly with increased number of positive nodes and increased ratio of positive to total nodes removed.
CONCLUSIONS: Improved survival in node negative cases of breast carcinoma may be due to removal of undetected micrometastases. Women diagnosed at more advanced stages as well as black women may also benefit from more extensive lymphadenectomy.

Entities:  

Mesh:

Year:  2005        PMID: 15868427     DOI: 10.1007/s10549-004-6276-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  9 in total

1.  Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.

Authors:  Emin Yildirim; Ugur Berberoglu
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

2.  Optimal management of sentinel lymph node positive biopsy patients in early breast cancer.

Authors:  Geraldine M Jacobson; Jessica F Partin; Mohamad A Salkeni
Journal:  Ann Transl Med       Date:  2015-05

3.  The value of positive lymph nodes ratio combined with negative lymph node count in prediction of breast cancer survival.

Authors:  Jing Yang; Quanyi Long; Hongjiang Li; Qing Lv; Qiuwen Tan; Xiaoqin Yang
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

4.  Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer.

Authors:  Vincent Vinh-Hung; Sue A Joseph; Nadege Coutty; Bevan Hong Ly; Georges Vlastos; Nam Phong Nguyen
Journal:  Oncologist       Date:  2010-10-07

5.  Issues related to sentinel lymph node assessment in the management of breast cancer-what are relevant in pathology reports?

Authors:  Patricia Tai; Kurian J Joseph; Edward Yu
Journal:  Patholog Res Int       Date:  2011-03-15

6.  The prognostic value of the nodal ratio in N1 breast cancer.

Authors:  Tae Jin Han; Eun Young Kang; Wan Jeon; Sung-Won Kim; Jee Hyun Kim; Yu Jung Kim; So Yeon Park; Jae Sung Kim; In Ah Kim
Journal:  Radiat Oncol       Date:  2011-10-06       Impact factor: 3.481

7.  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis.

Authors:  Nüvit Duraker; Bakır Batı; Davut Demir; Zeynep Civelek Caynak
Journal:  ISRN Oncol       Date:  2011-10-12

8.  Using nodal ratios to predict risk of regional recurrences in patients treated with breast conservation therapy with 4 or more positive lymph nodes.

Authors:  William Castrucci; Donald Lannin; Bruce G Haffty; Susan A Higgins; Meena S Moran
Journal:  ISRN Surg       Date:  2011-06-30

9.  Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection.

Authors:  Thalia Erbes; Marzenna Orlowska-Volk; Axel Zur Hausen; Gerta Rücker; Sebastian Mayer; Matthias Voigt; Juliane Farthmann; Severine Iborra; Marc Hirschfeld; Philipp T Meyer; Gerald Gitsch; Elmar Stickeler
Journal:  BMC Cancer       Date:  2014-01-03       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.